RESULTS	At month 24 , 9 % of ranibizumab-treated patients from MARINA and 10 % of ranibizumab-treated patients from ANCHOR had lost 15 letters VA ; 30 % of ranibizumab-treated patients from MARINA and 38 % of ranibizumab-treated patients from ANCHOR had gained 15 letters VA. .\